Malnutrition, muscle, wasting and cachexia in chronic heart failure: The nutritional approach

Italian Heart Journal

Volumn 4, Issue 4, 2003, Pages 232-235

  Pasini, Evasio ^a   Aquilani, Roberto ^a   Gheorghiade, Mihai ^b   Dioguardi, Francesco Saverio ^c  

^a IRCCS   (Italy)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Heart failure; Muscles; Nutrition

Indexed keywords

ALBUMIN; AMINO ACID; CYTOKINE; GLUCOSE; GROWTH HORMONE; INSULIN; SOMATOMEDIN;

ADIPOCYTE; AMINO ACID COMPOSITION; AMINO ACID METABOLISM; ARTICLE; CACHEXIA; COMORBIDITY; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE COURSE; DISEASE SEVERITY; GLUCONEOGENESIS; HEART FAILURE; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; INSULIN RESISTANCE; LIVER METABOLISM; MALNUTRITION; MEDICAL LITERATURE; MEDICAL RESEARCH; MUSCLE ATROPHY; MUSCLE METABOLISM; PANCREAS FUNCTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SKELETAL MUSCLE; STARVATION;

AMINO ACIDS; BLOOD GLUCOSE; CACHEXIA; HEART FAILURE, CONGESTIVE; HUMANS; MALNUTRITION; MUSCLE, SKELETAL; WASTING SYNDROME;

EID: 0037559772     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mancini DM, Walter G, Reichek N, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1999; 85: 1364-73.
2. Aquilani R, Opasich C, Cobelli F, Riccardi R, Tavazzi L, Baiardi P. Lo stato nutrizionale nello scompenso cardiaco cronico. Rivista Italiana di Nutrizione Parenterale ed Enterale 1994; 12: 1-9.
3. Rady MY, Ryan T, Star NJ. Clinical characteristics of preoperative hypoalbuminemia predict outcome of cardiovascular surgery. JPEN J Parenter Enteral Nutr 1997; 21: 81-90.
4. Gariballa SE, Stuart GP, Taub N, Castleden CM. Influence of nutritional status on clinical outcome after acute stroke. Am J Clin Nutr 1998; 68: 275-81.
5. Daniel PM, Pratt OE, Spargo E. The metabolic homeostatic role of muscle and its function as a store of protein. Lancet 1977; 27: 446-8.
6. Lehninger A. Biochemistry. New York, NY: Worth Publishers, 1975.
7. Anker SD, Swan JW, Volterrani M, et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J 1996; 18: 259-69.
8. Anker SD, Rauchhaus M. Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. Curr Opin Cardiol 1999; 14: 211-6.
9. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992; 13: 151-3.
10. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe heart failure. N Engl J Med 1990; 323: 236-41.
11. Packer M. Neurohormonal interactions in congestive heart failure. Circulation 1988; 77: 721-30.
12. Sasayama S, Matsumori A, Kihara Y. New insights into the pathophysiological role for cytokines in heart failure. Cardiovasc Res 1999; 42: 557-64.
13. Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999; 21: 1276-83.
14. Swan JW, Anker SD, Walton C, et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 1997; 30: 527-32.
15. Brouns F, van der Vusse GJ. Utilization of lipids during exercise in human subjects: metabolic and dietary constraints. Br J Nutr 1998; 79: 117-28.
16. Timmons JA, Gustafsson T, Sundberg CJ, et al. Substrate availability limits human skeletal muscle oxidative ATP regeneration at the onset of ischemic exercise. J Clin Invest 1998; 101: 79-85.
17. Deswal A, Bozkurt B, Seta Y, et al. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enabrel, etanercept) in patients with advanced heart failure. Circulation 1999; 99: 3224-6.
18. Dioguardi FS. Influence of the ingestion of branched chain amino acids on plasma concentrations of ammonia and free fatty acids. J Strength Cond Res 1997; 11: 242-5.
19. Patti ME, Brambilla E, Luzi L, Landacker EJ, Kahn CR. Bidirectional modulation of insulin action by amino acids. J Clin Invest 1998; 101: 1519-29.
20. Mosoni L, Houlier ML, Ptureau-Mirand P, Bayle G, Grizard J. Effect of amino acids alone or with insulin on muscle and liver protein synthesis in adult and old rats. Am J Physiol 1993; 264: E614-E620.
21. Giordano M, Castellino P, De Fronzo A. Differential responsiveness of protein synthesis and degradation to amino acid availability in humans. Diabetes 1996; 45: 393-9.
22. Le Roith D. Insulin-like growth factors. N Engl J Med 1996; 336: 633-40.
23. Quiong L, Baosheng L, Xiaowei W, et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress and cardiac hypertrophy. J Clin Invest 1997; 100: 1991-9.
24. Hesketh JE, Vasconcelos MH, Bermano G. Regulatory signals in messenger RNA: determinants of nutrient-gene interaction and metabolic compartmentation. Br J Nutr 1998; 80: 307-21.
25. Traxinger RR, Marshall S. Role of amino acids in modulating glucose-induced desensitization of the glucose transport system. J Biol Chem 1989; 264: 20910-6.
26. Garlick PJ, Mc Nurlan MA, Patlack CS. Adaptation of protein metabolism in relation to limits to high dietary protein intake. Eur J Clin Nutr 1999; 53 (Suppl 1): S34-S43.
27. Millward DJ, Rivers JPW. The nutritional role of indispensable amino acids and the metabolic basis for their requirements. Eur J Clin Nutr 1988; 42: 367-93.
28. Waterlow JC. The requirements of adult man for indispensable amino acids. Eur J Clin Nutr 1996; 50 (Suppl 1): S151-S179.